Journal article icon

Journal article

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.

Abstract:

Neuroendocrine tumours (NETs) constitute a heterogeneous group of tumours that frequently express cell membrane-specific peptide receptors, such as somatostatin receptors (SSTRs), and of which gastroenteropancreatic (GEP), carcinoid and pancreatic islet cell tumours exhibit the highest expression of SSTRs. Radiolabelled receptor-binding somatostatin analogues (octreotide and lanreotide) act as vehicles to guide radioactivity to tissues expressing SSTRs, and can thus be used for their diagnosi...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1677/erc.1.01116

Authors


Kaltsas, GA More by this author
Papadogias, D More by this author
Grossman, AB More by this author
Journal:
Endocrine-related cancer
Volume:
12
Issue:
4
Pages:
683-699
Publication date:
2005-12-05
DOI:
EISSN:
1479-6821
ISSN:
1351-0088
URN:
uuid:04f9c1c7-0844-45bc-af71-8f5df7a80f0b
Source identifiers:
138237
Local pid:
pubs:138237

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP